Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
about
Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI studySystemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.Cognitive training for improving executive function in chemotherapy-treated breast cancer survivorsChemotherapy-related cognitive impairment in older patients with cancerCancer- and cancer treatment-associated cognitive change: an update on the state of the scienceRenaming "chemobrain"Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging studyCognitive function in breast cancer survivors compared to healthy age- and education-matched women.Instruments for estimation of health-related quality of life in patients with skull base neoplasmsOpening up the window into "chemobrain": a neuroimaging reviewCognitive complaints in cancer: The French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), normative data from a healthy population.Cognitive speed of processing and functional declines in older cancer survivors: an analysis of data from the ACTIVE trialPsychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer.Memory and cancer: a review of the literatureWhat do perceived cognitive problems reflect?Regional brain activation during verbal declarative memory in metastatic breast cancerAbnormal Development of Dendrites in Adult-Born Rat Hippocampal Granule Cells Induced by Cyclophosphamide.Prevalence, mechanisms, and management of cancer-related cognitive impairment.Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domainsA framework for assessment in oncology rehabilitation.Altered small-world properties of gray matter networks in breast cancerSelf-reported cognitive concerns and abilities: two sides of one coin?Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.Symptom management of affective and cognitive disturbance with a group of cancer survivorsBehavioral symptoms in patients with breast cancer and survivors.Cognitive function in breast cancer patients prior to adjuvant treatmentThe Relationship between Visuospatial Memory and Coping Strategies in Breast Cancer Survivors.An update on cancer- and chemotherapy-related cognitive dysfunction: current status.Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapyFrontal hypometabolism in elderly breast cancer survivors determined by [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot studyA meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer.Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsThe association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatmentDifferential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research.Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice
P2860
Q21129407-253A76D7-09C5-41DE-87E2-930C7E0DD298Q21146752-725E7313-357F-4AB7-B7A5-5306D6C6204EQ24594173-C8EC489B-1F7D-4D62-8064-1A870B5307DFQ26747612-CCC490BA-C8C1-40B8-AF5C-86DFE5028566Q26853289-137ABC82-F01D-4CC6-AC32-7BA8D4EA930AQ28249848-17B96BD6-AA75-4CDC-B73C-FB370B6F7F75Q29395298-6B111D51-97F2-4B68-A6B6-F4C6E2C9261EQ30458869-E77B6C85-7F72-4D14-A84C-B3D7C33F38CEQ30480848-5B750B40-F221-4549-AE43-BC5E22F7000EQ30596880-D24C0FBC-745F-4B5B-801D-8E90A2673D2BQ30945359-4D110634-3124-49C1-9AA6-32911F3AF61BQ33496945-2341E2EF-91DF-4B2D-9B6D-115BE4739E96Q33570551-9E191D3A-4883-49DC-A7CC-C8D952467535Q33663544-09D84556-4A5A-443F-A7A5-B28F3468DB16Q33707551-FEADCA90-3A0B-4E8F-95A3-694479B0D9E7Q33810520-51B3BDF7-BA14-4A4A-B3CE-35B0E75EFFCFQ33819242-0DE83A36-A04F-4C45-B961-95D462CE8B4FQ33854977-C98254FE-957E-43B6-ABF9-77D5BF6489E5Q34031141-C40B369B-C99A-489C-BC87-A676580C101AQ34152165-CD90C50D-3E44-44EE-93FF-3EE49526F232Q34259686-D08A890A-9959-4898-8178-37680D9228F1Q34282795-30D60634-DF37-4722-ADA4-CC6A87D38AE0Q34288191-7740AFA2-5F35-4CCB-BF61-E6CF16FA32CCQ34334920-CB28D871-D624-4EAF-A8F4-7B02B9BA56E8Q34395112-D23A926B-2273-4B31-B32C-A61A356D358AQ34402534-21066A26-B763-4607-BF14-F849DDA3C44DQ34587999-6EAAB08A-1410-48C2-9B1C-8AF7E0A8F035Q34674401-7A140C08-3FD7-45BD-B6A3-618AD5EF80A5Q34675620-D283452D-D7E7-47D3-841D-B958DC97FFC4Q35043593-D7A581D7-E629-4E07-B0DF-9401DCCA38D3Q35052530-19697A0E-7078-445B-A7A5-B80ECEAB975CQ35059702-3B75E1D3-A745-4F8E-94DE-5FEF0CC0E4D3Q35116057-6A6F8286-B953-4834-804C-F55F85BAEB02Q35133442-D9D302C1-64ED-41F1-AD56-79A48E638100Q35161191-7C07EA70-B838-447A-B563-3AF03C19728AQ35164117-DA00F24D-32CA-48AB-9D5D-3090D86277BFQ35446931-E581FB3D-C18C-47A5-AFFB-0A9B23156D0AQ35535907-43A02E0B-DE87-4A05-B502-4732222AC655Q35556085-48BE2374-74A9-4C9A-9D9E-A067A2166FC1Q35577375-41888171-47D2-423B-9BEF-C0EBFF330A32
P2860
Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Neurocognitive performance in ...... nt chemotherapy and tamoxifen.
@en
Neurocognitive performance in ...... nt chemotherapy and tamoxifen.
@nl
type
label
Neurocognitive performance in ...... nt chemotherapy and tamoxifen.
@en
Neurocognitive performance in ...... nt chemotherapy and tamoxifen.
@nl
prefLabel
Neurocognitive performance in ...... nt chemotherapy and tamoxifen.
@en
Neurocognitive performance in ...... nt chemotherapy and tamoxifen.
@nl
P2093
P2860
P1476
Neurocognitive performance in ...... nt chemotherapy and tamoxifen.
@en
P2093
Gail A Greendale
Julienne E Bower
Laura Abraham
Laura Petersen
Patricia A Ganz
Steven A Castellon
P2860
P304
P356
10.1080/13803390490510905
P577
2004-10-01T00:00:00Z